Obesity is a definitive risk factor of severity and mortality in acute pancreatitis:: An updated meta-analysis

被引:235
|
作者
Martinez, J.
Johnson, C. D.
Sanchez-Paya, J.
de Madaria, E.
Robles-Diaz, G.
Perez-Mateo, M.
机构
[1] Hosp Gen Univ Alicante, Dept Gastroenterol, ES-03010 Alicante, Spain
[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Pancreat Unit, Mexico City, DF, Mexico
关键词
obesity; body mass index; acute pancreatitis;
D O I
10.1159/000092104
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Obesity is considered a risk factor in patients with acute pancreatitis. However, the relationship between obesity and mortality in this disease has not been confirmed definitively even in a previous meta-analysis. Since the publication of our previous meta-analysis, one study has been reported about the prognostic value of obesity in acute pancreatitis. We have performed a new meta-analysis to confirm the relationship between obesity and the outcome of acute pancreatitis. Data Sources: A MEDLINE search using 'pancreatitis', 'obesity' and 'body mass index' as search terms. Review Methods: Clinical studies which investigated the prognostic value of obesity in acute pancreatitis with the following criteria: (a) inclusion of mild and severe acute pancreatitis; (b) use of body mass index (BMI) as the measure of obesity; (c) definition of obesity as BMI <= 30 kg/ m(2); (d) definition of severity of acute pancreatitis according to the criteria established in the Atlanta Symposium. Five studies including patients with mild and severe acute pancreatitis and obesity measured by BMI were analyzed. The end points of the meta-analysis were the severity of acute pancreatitis, local complications, systemic complications and mortality. Pooled odds ratio (OR) and confidence intervals (CI) were calculated according to the Mantel-Haenszel method, and heterogeneity was assessed by the multiplicative inverse variance method. Results: Seven hundred and thirty-nine patients were included. There was no heterogeneity for the variables severity, systemic complications, local complications and mortality among the included studies. Severe acute pancreatitis was significantly more frequent in obese patients (OR 2.9, 95% CI 1.8-4.6). Furthermore, those patients developed significantly more systemic (OR 2.3, 95% CI 1.4-3.8) and especially local complications (OR 3.8, 95% CI 2.4-6.6). In this new analysis, mortality was also higher in obese patients (OR 2.1, 95% CI 1.0-4.8). Conclusion: Obesity is not only a risk factor for the development of local and systemic complications in acute pancreatitis: it also increases the mortality of this disease. Copyright (C) 2006 S. Karger AG, Basel and IAP.
引用
收藏
页码:206 / 209
页数:4
相关论文
共 50 条
  • [41] STATIN USE AND THE RISK OF ACUTE PANCREATITIS: A META-ANALYSIS OF OBSERVATIONAL STUDIES
    Archibugi, L.
    Poropat, G.
    Korpela, T.
    Cardenas Jaen, K.
    De-Madaria, E.
    Capurso, G.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E88 - E88
  • [42] Risk of acute pancreatitis with methimazole use: a systematic review and meta-analysis
    Bhagavathula, Akshaya Srikanth
    Clark, Cain
    Rahmani, Jamal
    DRUGS & THERAPY PERSPECTIVES, 2021, 37 (10) : 480 - 486
  • [43] Body mass index and the risk and prognosis of acute pancreatitis: a meta-analysis
    Shen Hong
    Ben Qiwen
    Jiang Ying
    An Wei
    Tong Chaoyang
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (12) : 1136 - 1143
  • [44] Gene polymorphisms in the interleukins gene and the risk of acute pancreatitis: A meta-analysis
    Zhu, Xiaole
    Hou, Chaoqun
    Tu, Min
    Shi, Chenyuan
    Yin, Lingdi
    Peng, Yunpeng
    Li, Qiang
    Miao, Yi
    CYTOKINE, 2019, 115 : 50 - 59
  • [45] Risk of acute pancreatitis with methimazole use: a systematic review and meta-analysis
    Akshaya Srikanth Bhagavathula
    Cain Clark
    Jamal Rahmani
    Drugs & Therapy Perspectives, 2021, 37 : 480 - 486
  • [46] Enteral Nutrition and the Risk of Mortality and Infectious Complications in Patients With Severe Acute Pancreatitis A Meta-analysis of Randomized Trials
    Petrov, Maxim S.
    van Santvoort, Hjalmar C.
    Besselink, Marc G. H.
    van der Heijden, Geert J. M. G.
    Windsor, John A.
    Gooszen, Hein G.
    ARCHIVES OF SURGERY, 2008, 143 (11) : 1111 - 1117
  • [47] Obesity and periodontitis: A systematic review and updated meta-analysis
    Kim, Chang Min
    Lee, Soobin
    Hwang, Wonjun
    Son, Eunjeong
    Kim, Tae Woo
    Kim, Kihun
    Kim, Yun Hak
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [48] ELEVATED BODY MASS INDEX INCREASES RISK OF MORTALITY IN PATIENTS WITH ACUTE PANCREATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Wang, Danlu
    Prichard, Wesley
    Barkin, Jodie A.
    Stein, Amy
    Reddy, Sudhakar
    Barkin, Jamie S.
    GASTROENTEROLOGY, 2019, 156 (06) : S1045 - S1046
  • [49] Hemoconcentration is an independent risk factor for mortality in acute pancreatitis
    Wu, Bechien
    Johannes, R. S.
    Kurtz, S.
    Tabak, Y.
    Banks, P. A.
    PANCREAS, 2006, 33 (04) : 507 - 508
  • [50] Prediction of the severity of acute pancreatitis on admission by urinary trypsinogen activation peptide: A meta-analysis
    Huang, Wei
    Altaf, Kiran
    Jin, Tao
    Xiong, Jun-Jie
    Wen, Li
    Javed, Muhammad A.
    Johnstone, Marianne
    Xue, Ping
    Halloran, Christopher M.
    Xia, Qing
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (28) : 4607 - 4615